|Ahead of print publication
A review on clinical and experimental studies on ayurveda and leukemia
Swati Chauhan1, Shalini Rai1, Vitthal G Huddar2
1 Department of Roga Nidan Avum Vikriti Vigyan, All India Institute of Ayurveda, New Delhi, India
2 Department of Kayachikitsa, All India Institute of Ayurveda, New Delhi, India
|Date of Submission||10-Sep-2019|
|Date of Decision||18-Jun-2020|
|Date of Acceptance||07-Jul-2020|
Department of Roga Nidan Avum Vikriti Vigyan, All India Institute of Ayurveda, Gautampuri, Saritavihar, New Delhi - 110 076
Source of Support: None, Conflict of Interest: None
Blood cancers such as leukemia are a public health crisis globally. 2018 cancer statistics reveal 437,033 new cases with leukemia accounting for 2.6% of all cancers, worldwide. Conventional medical science manages the disease quite effectively by targeting the signaling pathways causing leukemogenesis, but with serious side effects as it also damages healthy cells. In this context, a systematic review was carried out to understand the role of Ayurvedic interventions for the management of Rakta arbuda in context to leukemia. Articles were searched using the keywords “only Raktarbuda or leukemia” and “Ayurveda” and “management” or “case report” or “case series” or “in vivo” or “in vitro” “research or review” or “leukemia and Ayurveda” and their different combinations and permutations. Articles from 2000 to 2018, published in only English language, and related to the topic were screened for their contents, and finally, 88 articles were included in this review, which was studies exclusively focused on leukemia done using an Ayurvedic intervention in the form of case reports or case series, in vivo, in vitro studies, or review article. Some case reports were found which documented the beneficial effect of Ayurvedic interventions in the management of leukemias. Scientific researches documented that drugs such as Withania somnifera (Ashwagandha), Tinospora cordifolia (Guduchi), Curcuma longa (Haridra), Zingiber officinale (Adrak), Berberis aristata (Daruharidra), and Moringa oleifera (Sahijan) are efficient inducers of apoptosis. Cell line studies have demonstrated the efficacy of Andrographolide and methanolic extracts of Andrographis paniculata (Kalmegh), Semecarpus anacardium (Bhallataka), and Curculigo orchioides (Kali musli) against leukemia cell lines.
Keywords: Ayurveda, leukemia, management, Rakta arbuda, research
| Introduction|| |
Leukemia, ranked among the top ten cancer killers globally, is a type of cancer affecting the blood and bone marrow and causing uncontrolled growth of abnormal white blood cells. Leukemia clinically presents in two forms – (i) acute (rapidly progressing) disease characterized as acute lymphocytic leukemia and acute myelogenous leukemia and (ii) chronic (slowly progressing) forms as chronic lymphocytic leukemia (CLL) and chronic myelogenous leukemia (CML). Acute Lymphocytic Leukemia (ALL) is the most common of pediatric malignancies accounting for one-fourth of all childhood cancers and three-fourth of all freshly diagnosed leukemia cases. The incidence of childhood ALL is nearly 3–4 cases per 100,000 children under the age of 15 years. In India, nearly 25,000 children per annum are diagnosed with this cancer. AML accounts for approximately 20% of acute leukemia in children and 80% of acute leukemia in adults. According to the most recent data, leukemia accounted for 2.5% of all cancers and 3.2% of all deaths, while other forms of blood cancer such as Hodgkin's lymphoma represented 0.5% of all cancers and 0.5% of cancer deaths. 2018 cancer statistics reveal 437,033 new cases with leukemia accounting for 2.6% of all cancers globally.
Management in contemporary medicine includes chemotherapy (the use of anticancer drugs), radiation therapy (in which the high-energy radiation is used to kill cancer cells), and bone marrow transplant (in which transplantation of blood-forming stem cells is done after high doses of chemotherapy and radiation therapy as required) along with other supportive treatment as platelet transfusion to control bleeding. Conventional medical science manages the disease quite effectively by targeting the signaling pathways causing leukemogenesis, but with serious side effects as it also damages healthy cells, leading to low survival rate and rate of cure.
Ayurveda may offer some solutions for the above as there are so many herbal, polyherbal, mineral, and herbomineral drugs, which may play a major role in the treatment of leukemia and many other blood cancers, with significant cure rate and fewer side effects than conventional therapies. Studies document the beneficial effect of Ayurvedic interventions in the management of different kinds of blood cancers. In this context, a qualitative review was carried out to understand the role of Ayurvedic interventions for the management of Rakta arbuda w.s.r. to leukemia.
| Methodology|| |
A review of the literature was carried out in two phases using Google, Google Scholar, PubMed, and hand search. Here, the term hand search refers to searching the articles from cross-references of the articles selected for review. It is a process of selection of articles based on their rationality, undertaken at the stage of eligibility and inclusion, which did not characteristically undergo the process of identification and screening.
Articles were searched using the keywords “only Raktarbuda or leukemia” and “Ayurveda and management or case report or case series or in vivo or in vitro research or review” or “leukemia and Ayurveda” or their different combinations and permutations. Articles from 2000 to 2018, published in only English language, and related to the topic were screened for their contents, and 88 articles were finally included in this review, which was studies exclusively focused on leukemia done using an Ayurvedic intervention in the form case reports or case series, in vivo, in vitro studies, or review article. This study adopted a narrative review approach instead of a quantitative approach as used in meta-analysis. Hence, no statistical analysis was carried out in this review. The studies that did not fall in these categories were excluded from the review.
Data extraction and analysis
In the initial part, the articles were recognized based on the objectives of the study. In the second phase, the articles identified based on the study objectives were pooled together for screening by reading the titles and thereafter the abstracts. Articles not satisfying the inclusion criteria were excluded at this stage. The eligible articles were further screened by reading the full texts, and those not meeting the inclusion criteria were excluded. By the end of this process, the eligible articles meeting the inclusion criteria were taken for the review.
Eighty-seven studies done on leukemia using Ayurvedic intervention were finally included for the review [Table 1].
|Table 1: The details of the kind and number of studies included in the review|
Click here to view
| Observation|| |
Management of blood cancers through Ayurveda: Human studies
Some case reports documented the effectiveness of different Ayurvedic drugs for their clinical efficacy in leukemia. A case report by Rathi and Rathi documented the beneficial effect of a multimineral preparation, accentuated with the juices of Shyama Tulsi (Ocimum sanctum), Bilva leaves (Aegle marmelos), Sadaphuli (Catharanthus roseus), other Tikta Rasatmaka Aushadhies (bitter taste compound formulation medicines – Rohitakarishta, Kumaryasava, and Lohasava) given through oral route coupled with the per rectal administration of Majjabasti (medicinal preparation of animal bone marrow) with Panchtikta Ghrita (Ghrita cooked with several bitter taste medicines), to demonstrate a great role in the management of a case of acute lymphoid leukemia (ALL). The same report also documented the benefit of the above-mentioned regimen in the other two cases of ALL in the first and third stages (in conjunction with conventional treatment). No major side effects were noticed in the treatment duration (even in the case with adjuvant chemotherapy), and liver and kidney function tests were normal.
Prakash studied the effect of some herbomineral medications consisting of Navjeevan, Valipani, Kamdhuda Rasa, and Prak- 20 in a relapsing case of Acute Myeloid Leukemia (AML). The report documents the therapy to be effective with the patient completing 12 years of disease-free survival till then. Another case study by Prakash et al. in acute promyelocytic leukemia (APL) reported the efficacy of the treatment with complete disease remission and has completed 13 years of disease-free healthy life with the alternative treatment without any adverse side effect. Both the above case reports documented the use of antibiotics and blood transfusions being provided to the patient, under the supervision of experts of modern medicine in the initial treatment period as and when required.
A case study by Sharma on AML using several Ayurvedic drugs documents significant changes in signs and symptoms of the patient with simultaneous improvement in their blood investigations after 2 months of therapy. The details of these studies are summarized in [Table 2].
|Table 2: Case reports on the role of Ayurvedic interventions in different types of Leukaemia|
Click here to view
Ayurveda drugs and their efficacy in leukemias: In vitro and in vivo studies
Besides the above case reports, several other in vivo, in vitro researches, and review articles documented the efficacy of various herbal and herbomineral formulations studied for their efficacy in different types of leukemias. Satadru et al. reviewed the role of arsenic-based Ayurvedic compounds in the management of leukemia, and through the study of ancient classics and pieces of evidence from the contemporary researches, they found that Bhasmikarana process (the classical process of preparation of metal powders which converts them into nanoparticles) may enhance the bioavailability of the drug and hence potentiate its action. They also reported that there is a huge scope of the cellular apoptosis property of arsenic-containing drugs in combating leukemia. The same study has also quoted the work of Prakash and Prakash for documenting several success stories of APL in a pilot study.
Withania somnifera root aqueous extract (WRE) was proved to effectively modulate antioxidant activity, inflammatory cytokines, and cell death in human leukemia monocytic cell line (THP-1 cells). WRE was also found to decrease proinflammatory cytokine levels which may relieve cachexia due to cancer and excessive leukemic cell growth.,
Curcumin from the herb Curcuma longa (Haridra) has been discovered to modulate several regulatory proteins and inhibits carcinogenicity through the modulation of the cell cycle by binding to molecular targets directly and indirectly, including transcription factors (NF-kB, STAT3, β-catenin, and AP-1), growth factors (EGF, PDGF, and VEGF), enzymes (COX-2, iNOS, and MMPs), kinases (cyclin D1, CDKs, Akt, PKC, and AMPK), inflammatory cytokines (TNF, IL-1, and IL-6, MCP), upregulation of proapoptotic proteins (Bax, Bad, and Bak), and downregulation of antiapoptotic proteins (Bcl (2) and Bcl-xL). A variety of animal models and human studies have proven that curcumin is safe and well tolerated even at very high doses. A study of curcumin on acute and chronic myeloid leukemia cell lines, i.e., HL-60 and K562 cells, reveals different cellular mechanisms in chronic or acute myeloid leukemia cells and more potent antitumoral effect in K562 as compared with HL-60 cells.
Andrographolide, the major diterpene lactone extracted from Bhunimba (Andrographis paniculata), in the cell line studies is found to be cytotoxic toward several cancer cells, including lymphocytic leukemia and APL cells., They exhibit anticancer activities on cancer cells directly by arresting cell cycle at the G0/G1 phase through induction of cell cycle inhibitory protein and decreased expression of cyclin-dependent kinase.,
Gingerol from Zingiber officinale (Ardraka-Shunthi) has been demonstrated to induce apoptosis (programmed cell death) by a mitochondrial pathway in the leukemia cells K-562 along with exhibiting antioxidant, anti-inflammatory, and antitumor properties. Galanals from ginger on exposure to leukemia cells cause apoptosis, due to caspase-3 activation and induced DNA fragmentation.
Berberine, a natural isoquinoline alkaloid isolated from Berberis (Daruharidra), has been shown to induce apoptosis by topoisomerase II inhibition, stimulate caspase activation, and also exhibit antiproliferative, cytotoxic, and proapoptotic activities in leukemia, which lack p53 expression. Studies have also proved berberine to demonstrate anticancer activities against leukemic cells – HL-60 and WEHI-3.,
Cell lines' study with oil of Semecarpus anacardium (Punarnava), Convolvulus pluricaulis (Shankhpushpi), and Curculigo orchioides (musli) in leukemia cell lines has documented very promising positive results. A study of S. anacardium nut milk extract in leukemic mice showed clearance of the leukemic cells from the bone marrow and internal organs, a significant increase in lipid peroxides and glycolytic enzymes, a decrease in gluconeogenic enzymes, and a significant decrease in the activities of Krebs cycle and respiratory chain enzymes as compared to control animals.
A study on the proliferation and myeloid differentiation of the bone marrow hematopoietic precursor cells in mice-bearing transplantable T-cell lymphoma with the alcoholic extract of Tinospora cordifolia (Guduchi) whole plant indicates that T. cordifolia can influence the myeloid differentiation of bone marrow progenitor cells and the recruitment of macrophages in response to tumor growth in situ.
The study of wheatgrass methanolic extract in Wistar rats with benzene-induced leukemia revealed the antileukemic effect of the extract. Ethanolic extract of Moringa oleifera (Sahjan or Shigru) revealed antileukemic and antiproliferative effect on AML cell lines. Study of grape seed extracts on leukemia cell lines (Jurkat cells, U937, and HL-60) revealed that it causes cell death and induces apoptosis in leukemia cell lines through the activation of JNK pathway. Pomegranate (Punica granatum) juice extracts have been found to induce apoptosis in different leukemia cell lines (lymphoblastic cell lines – Jurkat, SUP-B15, MOLT-3, and CCRF-CEM and myeloblastic cell lines – HL-60, THP-1, K562, and KG1a). Carrot juice extract exposure to leukemia cell lines induced apoptosis and inhibited progression through the cell cycle. Lymphoid cell lines were affected to a greater extent than myeloid cell lines, and normal hematopoietic stem cells were less sensitive than most cell lines. Methanolic extract of Vacha (Acorus calamus) exhibits antineoplastic activity against P388 lymphocytic leukemia cell line due to epieudesmin. Active principles of Aloe vera (Aloe barbadensis) exhibit significant concentration-dependent cytotoxicity against acute myeloid leukemia (AML) and acute lymphocytes leukemia (ALL) cancerous cells. Saponoins from Asparagus shoot (Asparagus officinalis L) demonstrated antitumor activity inhibiting the growth of human leukemia HL-60 cells., Plumbagin from Chitraka (Plumbago zeylanica) is reported with anticancer activity against THP-1 cell line.
Laser-activated calendula extract of Marigold (Genda, Calendula officinalis) exhibited significant tumor cell proliferation inhibition through caspase-3-induced apoptosis and arrest of cell division at G0/G1 phase. Leukemic cell apoptosis is also exhibited by Senna (Senna alexandrina) plant extract. Amalaki (Emblica officinalis) was also found to be effective against leukemia cells in vivo. Potent antiproliferative and cytotoxic activity is shown against Jurkat cells (human leukemia cell line) by Kasani (Cichorium intybus) n-hexane extract. Karela (Momordica charantia) extract showed anticancer activity against lymphoid leukemia.,, Amooranin, a plant terpenoid from Rohitaka (Amoora rohituka) stem bark, exhibited significant cytotoxicity in multidrug-resistant human leukemia cell line with cell cycle perturbation in G2 + M phase. Mangiferin from mango (Mangifera indica) is also found to exhibit significant cytotoxic activity against K562 leukemia cell lines. Neem (Azadirachta indica) compounds liminoids and nimbolide are found to be effective against leukemic cell lines. Anti-inflammatory and proapoptotic effects have been reported via the modulation of the nuclear factor-kappa B pathway for methanolic neem (A. indica) leaf extract. β-sitosterol-3-O-β-D-glucoside isolated from ethanolic extract of dried neem leaves effectively reduced the proliferation of acute lymphoblastic leukemia (ALL) MOLT-4 cell lines in a dose- and time-dependent manner, with a check at G1 phase of cell cycle progression., Thymoquinone, an active component isolated from the seed extract of Kalaunji (Nigella sativa), exhibits antiproliferative effect, induces apoptosis, disrupts mitochondrial membrane potential, and triggers the activation of caspases 8, 9, and 3 in the myeloblastic leukemia HL-60 cells., Eugenol, a derivative of Tulasi (O. sanctum), exhibits mechanism of induced apoptosis in leukemia cell lines. Methanol extract of Mesua ferrea Linn. is found to be cytotoxic to T-lymphocyte leukemia cells. Ethanolic extract of Shallaki (Boswellia serrata) gum resin containing defined amount of boswellic acid-induced dose-dependent antiproliferative effects on all five leukemia (HL-60, K562, U937, MOLT-4, and THP-1) cell lines, with GI50 values (extract concentration producing 50% cell growth inhibition) between 57.0 and 124.1 μg/ml. The effect of total extract expressed in GI50 was 2.8, 3.3, and 2.3 times more potent (P < 0.05) than pure 3-O-acetyl-11-keto-beta-boswellic acid in three of the hematological cell lines (K562, U937, and MOLT-4). Zerumbone, a cyclic sesquiterpenoid of essential oil obtained from Kebuk (Costus speciosus), is a potential anticancer natural compound that shows activity on rat bone marrow cells, T-acute lymphoblastic leukemia cells. Methanol extract of flowers of Dhatura (Datura metel) has exhibited promising effects against K562 leukemia cell lines. Methanolic and hexane fractions of Sihora (Streblus asper) demonstrate highly cytotoxic potency against K-562 leukemia cell lines. Ananthamoola (Hemidesmus indicus) is found to induce cytotoxicity and alter cell cycle progression in human promyelocytic leukemia cell line (HL-60).,, Dimethyl-crocetin, crocetin, and crocin, the derivatives of Kesar (Crocus sativus), inhibit human CML K562 and promyelocytic leukemia HL-60 cells.
Rudanti (Astragalus species, Astragalus candolleanus and Astragalus malacophyllous),, extracts exhibit antitumor effects, specifically against melanoma and leukemia cell lines. Triphala (a combination of E. officinalis, Terminalia chebula, and Terminalia belerica) is a rich source of gallic acid which is reported to possess anticancer properties against leukemia cell lines. Exosome-like nanovesicles present in the juice of Nimbuka (Citrus limon) affect cell growth of leukemia cells, through activation of TRAIL-mediated apoptosis and also through angiogenesis inhibition. Guggulsterone from Guggulu (Commiphora mukul) inhibited the proliferation of drug-resistant leukemia cells.
A study of Kajjali (black sulfide mercury, HgS, a mineral compound purified and processed drug of Ayurveda) in chronic myeloid leukemic cells, K562 cell line with different concentrations revealed that increased concentrations of Kajjali significantly changed cell morphology and induced cell death by apoptosis. Another scientific study documented the beneficial effect of Abhraka Bhasma (incinerated nanoparticle of mica) on leukemia U937 cell lines.
Compounds of arsenic have demonstrated significant anticancer activity against leukemia cell lines, with arsenic trioxide (ATO, Somal or Gauripashana, As2O3) in acute megakaryocytic leukemia and realgar (Manhshila, As4S4,) on K562 and fresh CML mononuclear cells.,,,,
An in vivo study on albino mice with a herbomineral drug using purified arsenic (ATO), Vinca rosea, and Urginia indica and ATO as a control against myelocytic leukemia and lymphocytic leukemia was found to show good antileukemic activity and safety, though ATO produced better results.
| Discussion|| |
Leukemia is among the top ten global killers. 2018 cancer statistics reveal 437,033 new cases with leukemia accounting for 2.6% of all cancers globally. It is a type of cancer affecting the blood and bone marrow and causing uncontrolled growth of abnormal white blood cells. Leukemia is classified based on the onset and progression of the disease into acute or chronic. Based on the nature of cells involved in leukemia, it has been subdivided into further subtypes such as acute lymphoblastic leukemia (ALL), chronic lymphocytic leukemia (CLL), acute myelogenous leukemia (AML), CML, hairy cell leukemia (HCL), T-cell prolymphocytic leukemia (T-PLL), large granular lymphocytic leukemia, adult T-cell leukemia, juvenile myelomonocytic leukemia (JMML). Of these, ALL is the most common of pediatric malignancies accounting for one-fourth of all childhood cancer and three-fourth of all freshly diagnosed leukemia cases. CLL, AML, and CML are common in adults, though AML and CML may also affect children. AML accounts for approximately 20% of acute leukemia in children and 80% of acute leukemia in adults. HCL and T-PLL and large granular lymphocytic leukemia are relatively uncommon; however, while T-PLL is an aggressive form, large granular lymphocytic leukemia is nonaggressive. Human T-lymphotropic virus infection is associated with adult T-cell leukemia. JMML is a type of leukemia occurring in childhood with intermediate growth rate. The chief presenting features of leukemia in the patients are relatively unspecific and resemble the features of decreased immunity of the body. The patient suffers from fatigue, recurrent fevers and infections, loss of appetite, weight loss, swollen and palpable lymph nodes, bone and joint pains, bruising or bleeding, rashes, etc. Diagnostic tests include complete blood count, general blood picture, liver and kidney function tests, bone marrow aspiration and biopsy, lymph node biopsy, genetic studies, and spinal tap. The conventional medical system has developed a plethora of modalities for managing the disease with chemotherapy, radiation therapy, immunosuppression therapy, bone marrow transplants, splenectomy, and stem cell transplantation, and still, many more modalities are being researched to combat the disease. The treatment is aimed at improving the prognosis of the disease, as the treatment is associated with several dreaded side effects such as tumor lysis syndrome (with several metabolic abnormalities such as hyperkalemia, hyperuricemia, hyperphosphatemia, raised blood urea nitrogen, and hypocalcemia) and several features due to the damage of healthy cells, besides the neoplastic cells, resulting in bruising or bleeding, impaired immunity, alopecia, fatigue, anorexia, nausea, vomiting, nephropathy, acute kidney failure, cardiac arrhythmias, seizures, and even death. Due to the above-mentioned reasons, the search for better treatment interventions is the need of the hour with better efficacy and minimized side effects.
Ayurveda is being used for the management of many diseases in India since ages. Ayurveda has the description of many ailments specifically by name and describes the treatment principles for other ailments that may present in the patients based on Dosha (the particular physiological Dosha), Dushya (tissue involved), Adhishthana (the seat of the disease), and Hetu (etiological factor). Based on the above principles of Ayurveda, and based on knowledge about the drugs (herbs, minerals, herbomineral, and animal origin), any disease can be managed quite effectively. Acting on the body, these drugs also heal, potentiate, and regenerate the body to combat the disease itself besides directly targeting the abnormal cell growth. They also target and improve the digestive system and liver as proper digestion is the basis for health as per Ayurveda. Ayurveda recommends for the early diagnosis and management of diseases, as once a disease becomes deep-rooted in the body, it will be difficult to uproot it completely and it will cause significant damage to the body.
Leukemia as such is not described in Ayurveda; however, there are guidelines based on which any disease can be treated. These are based on the presentations of the patient. The presenting features of leukemia are summarized with their correlating diseases and features [Table 3].
|Table 3: Ayurveda guidelines for deriving the treatment principle of leukemia|
Click here to view
In the case reports documented above, it is very apparent that the treatment module adopted by the physicians in these patients was based on the concept of vitiation of blood (Rakta Dushti) and the pacification of Pitta (Pitta Shaman). The nature and properties of Rakta (blood) are similar to that of Pitta Dosha (one of the three physiological entities of the body responsible for all the functions of digestion, metabolism, inflammation, heat generation, etc.). Hence, formulations balancing Pitta will also bring Rakta in equilibrium, and vice versa. Further, all treatment principles adopted for purification of Rakta, also simultaneously address the organs liver (called as Yakrita) and spleen (called as Pleeha), which have been especially linked to blood as its root organs (Moola).
An observation of the drugs used above reveals that the majority of the drugs are mainly Pitta Shamaka (drugs pacifying Pitta), Rakta Shodhaka (purifying blood), Agni Vardhaka (correcting metabolism and acting on the liver) and having Rasayana (rejuvenating) properties as per the Ayurvedic concept. Heeraka bhasma (processed and incinerated diamond ash) and Bhallataka (S. anacardium) are the drugs described for the management of tumors in Ayurveda. Rajat bhasma (purified, processed, and incinerated silver ash) as per the concept of Samanya (similarity) in Ayurveda is a component of bone tissue and is supposed to act on white blood cells also. Every processed and incinerated Dhatu Bhasmas (metal ash) in Ayurvedic preparations are also combined with purified and processed Parad (mercury) and Gandhak (sulfur), to potentiate their action within the human body. Based on these principles, the medicines, Navjeevan and Valapani were prepared and used in the therapy of leukemia patients., The combination of Parada and Gandhak called as Kajjali in Ayurveda has also been proven to be an efficient inducer of apoptosis. The approach adopted by Prakash also points toward the integrated approach of Ayurveda and conventional experts in the management of leukemia with scientific documentation of data. That particular approach with adequate infrastructure within the same premises helps to save the leukemic patient during stages of crisis, with the help of scientific advancements, such as blood transfusions or any antibiotic course required, which may appear during treatment regimen.
A review of the drugs reported for their experimental efficacy against leukemia, as per the classical texts of Ayurveda, reveals the following properties, actions, and indications [Table 4].
|Table 4: The properties and actions of drugs (as per Ayurveda) studied experimentally in leukemia|
Click here to view
The exact methodology of action of these drugs as per the Ayurveda principle in cell line studies cannot be explained; however, it is observed that majority of herbal drugs studied experimentally were having Katu (pungent) and Tikta (bitter) tastes with hot potency and were mostly having properties of Kapha-Vata pacification, blood purification, digestive stimulant, nourishing, rejuvenate, etc. They could be acting on cell lines due to the above-mentioned properties. Reference of their classically being used in Arbuda (cancer) treatment is not available, except for Draksha (Vitis vinifera) and Haridra (C. longa).
Regarding the mineral preparations, Ayurveda describes that the drugs should be prepared only after proper purificatory measures and following proper methodology to attain the following properties in the final bhasma (incinerated ash) preparation – Nirmalatva (bitter less taste), Niscandratva (absence of any metallic luster), Rekha purnatva (penetrating in the finger ridges when held in between the thumb and index finger), Varitaratva (floating on the surface of water when a pinch of Kajjali or bhasma is dropped over it), Apunarbhava (the bhasma should not regain the elemental metal form on strong heating with jaggerry), Gunja (Abrus precatorius, honey and ghee), and Niruttha (Bhasma should not regain its metallic nature after strong heating with silver). The metal preparations studied experimentally, i.e., Kajjali (mercuric sulfide) as well as Abhraka bhasma (mica) as per the Ayurveda, are described to have the property of Rasayana (nourishing the body tissues). In addition, Kajjali has been described to be useful in curing abscesses (Vidradhi), cervical lymphadenopathy (Gandamala), warts (Charmadala), eryseplas (Visarpa), etc., while Abhraka bhasma (mica) is described to be useful in nonhealing wounds and abscesses (Dushta Vrana), bleeding diathesis (Rakta-pitta), tuberculosis (Rajayakshma), etc.
Regarding Somal (Gauripashana, ATO), it is mentioned in Rasatarangini that it stimulates the digestive fire and acts on fever, anemia, dyspnea, spleenomegaly, skin diseases, body strengthening, Rasayana (rejuvenative), etc. Manhshila (As4S4, realgar) is described as lekhana (scraping agent, removing excess tissues) and Rasayana (rejuvenative), acting on cough, dyspnea, fevers, itching, anemia, and other such diseases. These indications and properties make both these drugs a choice agent for leukemia management from Ayurveda perspective also, as it is resolving most of its symptom pathology. However, as per the Ayurveda, there are certain indications of diet and behavior which are to be followed while using these drugs.
These two drugs, i.e., Somal (ATO) and Manahshila (As4S4, realgar), are now very widely being studied for their potent anticancerous effects in patients of APL, by the scientists of conventional medical science demonstrating their efficacy and safety.
Many other compound drugs are described in Ayurveda texts for their potential usage in Arbuda (tumors) such as Hargauri rasa, Nityanand rasa, Raudra rasa, and Vriddhadaru churna, but clinical studies are yet lacking for the same.
Hence, many drugs have been evaluated and documented to be effective in experimental studies, but their translation into a potential drug has been achieved only in a limited manner for some drugs as vincristine, vinblastine from Sadanpushpa (Vinca rosea), and arsenic compounds. It is also evident from the clinical and experimental studies documented above that both of the groups are reflecting very different approaches. Each drug in Ayurveda is described with a diverse number of properties, targets, and actions, which is very different from the conventional system approach where reductionist approach is applied with one molecule and one target. Since a drug has numerous phytoconstituent molecules in it, they demonstrate diversified action on several body systems and they also exhibit antagonistic properties to some of their own molecules, resulting in the reduction or nullification of side effects when used judiciously, with proper indications. In most of the experimental studies, the extracts of plants are taken and studied in vivo or in vitro to observe their results. However, the behavior observed experimentally at bench side will translate equivalently in to clinical results at bedside is not assured, though they definitely form a first level of evidence for their efficacy against leukemia. The above-documented researches definitely present some evidence for the efficacy of Ayurveda drugs and treatment in leukemia, but the body of evidence is very small. Large sample size-based randomized controlled clinical trials are definitely, yet lacking for generating gold standard scientific evidence for the same. The authors propose to adopt the methodology adopted by Prakash et al. using integrated approach in conduction of future studies. This would help in effective management of all stages of patients under the domain experts and could hasten the recovery rates of the patients.
Besides being used as a main therapy for the management of leukemia cases, Ayurveda drugs can also be adopted as an adjuvant drug in the patients of leukemia placed on conventional treatment for chemotherapy or radiotherapy. Several studies have documented the beneficial effect of Ayurveda drugs in the reduction of side effects of radiotherapy, chemotherapy, and hastened recovery of the patients. Resveratrol (from grapes, Draksha) is reported as a potent chemoprotective and synergistic agent in cancer chemotherapy. Tulsi (Holy basil) is proven through experimental, preclinical, and clinical studies as an effective radioprotective agent. Similarly, Triphala (a combination of E. officinalis, T. chebula, and T. belerica), Guduchi (T. cordifolia), has been documented in studies to have radioprotective and/or chemoprotective effects. These drugs may also be assessed for their efficacy as a radio or chemopreventive agent in the treatment of leukemia patients placed on conventional therapy.
| Conclusion and Way Forward|| |
Significant numbers of leukemia patients in India try various systems of complementary and alternative medicine. The present study indicates that Ayurvedic medicines were effective in the treatment of major types of leukemia such as AML, APL, and CLL and did not produce any toxic side effects. An Ayurvedic approach like the one given here can be of some help to patients with relapses and nonresponsive to conventional leukemia treatment. The relapse observed in the patients even after undergoing the best of conventional therapy holds limited options for the patients. Integrated approach as documented by Prakash can be adopted to document the efficacy of Ayurveda drugs in these patients. The experimental studies conducted for leukemia will help in identifying and developing novel molecules against leukemia on the principles of conventional medical science, but that particular approach will be of any help to Ayurveda is questionable. However, randomized controlled trials with the Ayurveda approach in a larger sample size are needed to prove the safety and efficacy of Ayurveda drugs with more reliable evidence. Further, the efficacy of Ayurvedic drugs may also be assessed for their efficacy as a radio or chemopreventive agent in the treatment of leukemia patients placed on conventional therapy.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
| References|| |
Arora RS, Arora B. Acute leukemia in children: A review of the current Indian data. South Asian J Cancer 2016;5:155-60.
] [Full text]
Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al
. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 2015;136:E359-86.
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018;68:394-424.
Roy M, Mukherjee A, Mukherjee S, Biswas J. Nutraceuticals in leukemia. J Ayurved Herbal Med 2017;3:38-44.
Sharma VB. An Ayurvedic approach for acute myeloid leukemia. Int J Recent Adv Multidiscipl Res 2015;2:209-10.
Rathi R, Rathi B. A case report of acute lymphoblastic leukemia – An Ayurvedic approach. Ayurpharm Int J Ayur Alli Sci 2014;3:48-1.
Prakash B. Treatment of relapsed undifferentiated acute myeloid leukemia (AML-M0) with Ayurvedic therapy. Int J Ayurveda Res 2011;2:56-9.
] [Full text]
Prakash B, Parikh PM, Pal SK. Herbo-mineral Ayurvedic treatment in a high risk acute promyelocytic leukemia patient with second relapse: 12 years follow up. J Ayurveda Integr Med 2010;1:215-8.
] [Full text]
Sharma VB. An Ayurvedic approach for acute myeloid leukaemia. Int J Recent Adv Multidiscipl Res 2015;2:209-10.
Palbag S, Gautam DN. Arsenic in the management of leukemia: An Ayurvedic perspective. J Ayurved Herbal Med 2017;3:159-62.
Naidoo DB, Chuturgoon AA, Phulukdaree A, Guruprasad KP, Satyamoorthy K, Sewram V. Withania somnifera
modulates cancer cachexia associated inflammatory cytokines and cell death in leukaemic THP-1 cells and peripheral blood mononuclear cells (PBMC's). BMC Complement Altern Med 2018;18:126.
Oza VP, Parmar PP, Kumar S, Subramanian RB. Anticancer properties of highly purified L-asparaginase from Withania somnifera L. against acute lymphoblastic leukemia. Appl Biochem Biotechnol. 2010;160(6):1833-40.
Shehzad A, Lee J, Lee YS. Curcumin in various cancers. Biofactors 2013;39:56-68.
Martínez-Castillo M, Villegas-Sepúlveda N, Meraz-Rios MA, Hernández-Zavala A, Berumen J, Coleman MA, et al
. Curcumin differentially affects cell cycle and cell death in acute and chronic myeloid leukemia cells. Oncol Lett 2018;15:6777-83.
Rajagopal S, Kumar RA, Deevi DS, Satyanarayana C, Rajagopalan R. Andrographolide, a potential cancer therapeutic agent isolated from Andrographis paniculata
. J Exp Ther Oncol 2003;3:147-58.
Manikam SD, Stanslas J. Andrographolide inhibits growth of acute promyelocytic leukaemia cells by inducing retinoic acid receptor-independent cell differentiation and apoptosis. J Pharm Pharmacol 2009;61:69-78.
Kumar RA, Sridevi K, Kumar NV, Nanduri S, Rajagopal S. Anticancer and immunostimulatory compounds from Andrographis paniculata
. J Ethnopharmacol 2004;92:291-5.
Satyanarayana C, Deevi DS, Rajagopalan R, Srinivas N, Rajagopal S. DRF 3188 a novel semi-synthetic analog of andrographolide: Cellular response to MCF 7 breast cancer cells. BMC Cancer 2004;4:26.
Zeng HL, Han XA, Gu C, Zhu HY, Huang XS, Gu JQ, et al
. Reactive oxygen species and mitochondrial membrane potential changes in leukemia cells during 6-gingerol induced apoptosis. Zhong Yao Cai 2010;33:584-7.
Miyoshi N, Nakamura Y, Ueda Y, Abe M, Ozawa Y, Uchida K, et al
. Dietary ginger constituents, galanals A and B, are potent apoptosis inducers in human T lymphoma Jurkat cells. Cancer Lett 2003;199:113-9.
Lin CC, Kao ST, Chen GW, Chung JG. Berberine decreased N-acetylation of 2-aminofluorene through inhibition of N-acetyltransferase gene expression in human leukemia HL-60 cells. Anticancer Res 2005;25:4149-55.
Liu J, Zhang X, Liu A, Liu S, Zhang L, Wu B, et al
. Berberine induces apoptosis in p53-null leukemia cells by down-regulating XIAP at the post-transcriptional level. Cell Physiol Biochem 2013;32:1213-24.
Andola HC, Gaira KS, Rawal RS, Rawat MS, Bhatt ID. Habitat-dependent variations in berberine content of Berberis asiatica
Roxb. ex. DC. in Kumaon, Western Himalaya. Chem Biodivers 2010;7:415-20.
Kulkarni SK, Dhir A. Berberine: A plant alkaloid with therapeutic potential for central nervous system disorders. Phytother Res 2010;24:317-24.
Chakraborty S, Roy M, Taraphdar AK, Bhattacharya RK. Cytotoxic effect of root extract of Tiliacora racemosa
and oil of Semecarpus anacardium
nut in human tumour cells. Phytother Res 2004;18:595-600.
Tacchini M, Spagnoletti A, Marieschi M, Caligiani A, Bruni R, Efferth T, et al
. Phytochemical profile and bioactivity of traditional Ayurvedic decoctions and hydro-alcoholic macerations of Boerhaavia diffusa
L. and Curculigo orchioides
Gaertn. Nat Prod Res 2015;29:2071-9.
Sugapriya D, Shanthi P, Sachdanandam P. Restoration of energy metabolism in leukemic mice treated by a siddha drug--Semecarpus anacardium
Linn. nut milk extract. Chem Biol Interact 2008;173:43-58.
Singh SM, Singh N, Shrivastava P. Effect of alcoholic extract of Ayurvedic herb Tinospora cordifolia
on the proliferation and myeloid differentiation of bone marrow precursor cells in a tumor-bearing host. Fitoterapia 2006;77:1-1.
Khan N, Ganeshpurkar A, Dubey N, Bansal D. Immunoprophylactic potential of wheat grass extract on benzene-induced leukemia: An in vivo
study on murine model. Indian J Pharmacol 2015;47:394-7.
] [Full text]
Eltayb MD, Hussein AN. Amr. Antiproliferative action of Moringa oleifera
root extracts in acute myeloid leukemia (AML) cell line. J Exp Sci 2010;1(8):27-8.
Gao N, Budhraja A, Cheng S, Yao H, Zhang Z, Shi X. Induction of apoptosis in human leukemia cells by grape seed extract occurs via activation of c-Jun NH2-terminal kinase. Clin Cancer Res 2009;15:140-9.
Dahlawi H, Jordan-Mahy N, Clench MR, Le Maitre CL. Bioactive actions of pomegranate fruit extracts on leukemia cell lines in vitro
hold promise for new therapeutic agents for leukemia. Nutr Cancer 2012;64:100-10.
Zaini R, Clench MR, Le Maitre CL. Bioactive chemicals from carrot (Daucus carota
) juice extracts for the treatment of leukemia. J Med Food 2011;14:1303-12.
Pettit GR, Kamano Y, Herald CL. Antineoplastic agents, 118. Isolation and structure of bryostatin 9. J Nat Prod 1986;49:661-4.
El-Shemy HA, Aboul-Soud MA, Nassr-Allah AA, Aboul-Enein KM, Kabash A, Yagi A. Antitumor properties and modulation of antioxidant enzymes' activity by Aloe vera
leaf active principles isolated via supercritical carbon dioxide extraction. Curr Med Chem 2010;17:129-38.
Shao Y, Chin CK, Ho CT, Ma W, Garrison SA, Huang MT. Anti-tumor activity of the crude saponins obtained from asparagus. Cancer Lett 1996;104:31-6.
Shao Y, Poobrasert O, Kennelly EJ, Chin CK, Ho CT, Huang MT, et al
. Steroidal saponins from Asparagus officinalis and their cytotoxic activity. Planta Med 1997;63:258-62.
Sharma R, NAik S, Saroch V. Geographical variation in chemo profile, genetic profile and in-vitro anticancer activity of Chitraka (Pumbago zeylanica Linn.
) collected from Himalayas and Western Ghats. Journal of Ayurveda and Integrated Medical Sciences 2019; 4(4): 199-208.
Jiménez-Medina E, Garcia-Lora A, Paco L, Algarra I, Collado A, Garrido F. A new extract of the plant Calendula officinalis
produces a dual in vitro
effect: Cytotoxic anti-tumor activity and lymphocyte activation. BMC Cancer 2006;6:119.
Campos JF, de Castro DT, Damião MJ, Vieira Torquato HF, Paredes-Gamero EJ, Carollo CA, et al
. The chemical profile of Senna velutina
leaves and their antioxidant and cytotoxic effects. Oxid Med Cell Longev 2016;2016:8405957.
Zhao T, Sun Q, Marques M, Witcher M. Anticancer properties of Phyllanthus emblica
(Indian Gooseberry). Oxid Med Cell Longev 2015;2015:950890.
Saleem M, Abaas K, Nasser F, Ahmad M, Sayed NH, Javed F, et al
. Anticancer activity of n-hexane extract of Cichorium intybus
on lymphoblastic leukemia cells (Jurkat cells). Afr J Plant Sci 2014;8:315-9.
Bhragual DD, Kaushik S, Varuna K, Kumar N, Garg VK, Sharma PK. Review on herbal plants having anti-cancer activity. Pharmacologyonline 2010;1:683-700.
Raina K, Kumar D, Agarwal R. Promise of bitter melon (Momordica charantia) bioactives in cancer prevention and therapy. Semin Cancer Biol 2016;40-41:116-129. doi:10.1016/j.semcancer.2016.07.002
Cunnick JE, Sakamoto K, Chapes SK, Fortner GW, Takemoto DJ. Induction of tumor cytotoxic immune cells using a protein from the bitter melon (Momordica charantia
). Cell Immunol 1990;126:278-89.
Ramachandran C, Rabi T, Fonseca HB, Melnick SJ, Escalon EA. Novel plant triterpenoid drug amooranin overcomes multidrug resistance in human leukemia and colon carcinoma cell lines. Int J Cancer 2003;105:784-9.
Peng ZG, Luo J, Xia LH, Chen Y, Song SJ. CML cell line K562 cell apoptosis induced by mangiferin. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2004;12:590-4.
Das G, Gouda S, Mohanta YK, Patra JK. Mangrove plants: A potential source for anticancer agents. Indian J Geomarine Sci 2015;44:666-72.
Schumacher M, Cerella C, Reuter S, Dicato M, Diederich M. Anti-inflammatory, pro-apoptotic, and anti-proliferative effects of a methanolic neem (Azadirachta indica
) leaf extract are mediated via modulation of the nuclear factor-κB pathway. Genes Nutr 2011;6:149-60.
Sarkar S, Pal A, Chouni A, Paul S. A novel compound β-sitosterol-3-O-β-D-glucoside isolated from Azadirachta indica
effectively induces apoptosis in leukemic cells by targeting G0/G1 populations. Indian J Biochem Biophys 2020;57:27-32.
Chatterjee R, Singh O, Pachuau L, Malik SP, Paul M, Bhadra K, et al
. Identification of a sulfonoquinovosyldiacylglyceride from Azadirachta indica
and studies on its cytotoxic activity and DNA binding properties. Bioorg Med Chem Lett 2010;20:6699-702.
El-Mahdy MA, Zhu Q, Wang QE, Wani G, Wani AA. Thymoquinone induces apoptosis through activation of caspase-8 and mitochondrial events in p53-null myeloblastic leukemia HL-60 cells. Int J Cancer 2005;117:409-17.
Salim LZ, Othman R, Abdulla MA, Al-Jashamy K, Ali HM, Hassandarvish P, et al
. Thymoquinone inhibits murine leukemia WEHI-3 cells in vivo
and in vitro
. PLoS One 2014;9:e115340.
Jaganathan SK, Supriyanto E. Antiproliferative and molecular mechanism of eugenol-induced apoptosis in cancer cells. Molecules 2012;17:6290-304.
Nordin K, Ahmad FB, Taufiq YY, Ali AM. Volatile components of methanol extract from the flower of Malaysian Mesua ferrea
Linn. Oriental J Chem 2004;20:69-72.
Hostanska K, Daum G, Saller R. Cytostatic and apoptosis-inducing activity of boswellic acids toward malignant cell lines in vitro
. Anticancer Res 2002;22:2853-62.
Abdelwahab SI, Abdul AB, Mohan S, Taha MM, Syam S, Ibrahim MY, et al
. Zerumbone induces apoptosis in T-acute lymphoblastic leukemia cells. Leuk Res 2011;35:268-71.
Pan Y, Wang X, Hu X. Cytotoxic withanolides from the flowers of Datura metel
. J Nat Prod 2007;70:1127-32.
Rawat P, Kumar A, Singh TD, Pal M. Chemical composition and cytotoxic activity of methanol extract and its fractions of Streblus asper
leaves on human cancer cell lines. Pharmacogn Mag 2018;14:141-4.
Turrini E, Calcabrini C, Tacchini M, Efferth T, Sacchetti G, Guerrini A, et al
. In Vitro Study of the Cytotoxic, Cytostatic, and Antigenotoxic Profile of Hemidesmus indicus (L.) R.Br. (Apocynaceae) Crude Drug Extract on T Lymphoblastic Cells. Toxins (Basel). 2018;10(2):70.
Ferruzzi L, Turrini E, Burattini S, Falcieri E, Poli F, Mandrone M, et al
. Hemidesmus indicus
induces apoptosis as well as differentiation in a human promyelocytic leukemic cell line. J Ethnopharmacol 2013;147:84-91.
Turrini E, Catanzaro E, Ferruzzi L, Guerrini A, Tacchini M, Sacchetti G, et al
. Hemidesmus indicus
induces apoptosis via proteasome inhibition and generation of reactive oxygen species. Sci Rep 2019;9:7199.
Samarghandian S, Borji A. Anticarcinogenic effect of saffron (Crocus sativus
L.) and its ingredients. Pharmacognosy Res 2014;6:99-107.
Jia XH, Yin BH, Li JC. Effect of Astragalus
injection on U937 leukemia cells proliferation and apoptosis and relevant molecular mechanisms. Zhongguo Dang Dai Er Ke Za Zhi 2013;15:1128-33.
Kim SH, Lee SE, Oh H, Kim SR, Yee ST, Yu YB, et al
. The radioprotective effects of bu-zhong-yi-qi-tang: a prescription of traditional Chinese medicine. Am J Chin Med. 2002;30(1):127-37.
Podlech D, Zarre S. A taxonomic revision of the genus Astragalus L. (Leguminosae) in the Old World, Vienna Natural History Museum, Austria 2013;1-3:2439.
Chandramohan Reddy T, Bharat Reddy D, Aparna A, Arunasree KM, Gupta G, Achari C, et al
. Anti-leukemic effects of gallic acid on human leukemia K562 cells: Downregulation of COX-2, inhibition of BCR/ABL kinase and NF-κB inactivation. Toxicol In Vitro
Raimondo S, Naselli F, Fontana S, Monteleone F, Lo Dico A, et al
. Citrus limon-derived nanovesicles inhibit cancer cell proliferation and suppress CML xenograft growth by inducing TRAIL-mediated cell death. Oncotarget 2015;6:19514-27.
Shishodia S, Sethi G, Ahn KS, Aggarwal BB. Guggulsterone inhibits tumor cell proliferation, induces S-phase arrest, and promotes apoptosis through activation of c-Jun N-terminal kinase, suppression of Akt pathway, and downregulation of antiapoptotic gene products. Biochem Pharmacol 2007;74:118-30.
Sharma V, Siddiqui S, Singh RK, Arshad M, Chaudhary AK. Kajjali as a potent anti-leukemic and apoptosis-inducing Ayurvedic drug in chronic myeloid leukemic cells; K562 cell line. J Ayurveda Integ Med 2018;9 Suppl 1:S2.
Tamhankar YL, Gharote AP. Effect of Puta on in vitro
anticancer activity of Shataputi Abhrak Bhasma on lung, leukemia and prostate cancer cell lines. J Ayurveda Integr Med 2018. pii: S0975-9476 (17) 30102-X.
Lam HK, Li K, Chik KW, Yang M, Liu VC, Li CK, et al
. Arsenic trioxide mediates intrinsic and extrinsic pathways of apoptosis and cell cycle arrest in acute megakaryocytic leukemia. Int J Oncol 2005;27:537-45.
Shen JC, Liu KY, Jiang B, Lu XJ, Lu DP. Effect of the tetra-arsenic tetra-sulfide (As4
) on the corrected QT interval in the treatment of acute promyelocytic leukemia. Zhonghua Xue Ye Xue Za Zhi 2004;25:359-61.
Lu DP, Qiu JY, Jiang B, Wang Q, Liu KY, Liu YR, et al
. Tetra-arsenic tetra-sulfide for the treatment of acute promyelocytic leukemia: A pilot report. Blood 2002;99:3136-43.
Li JE, Wu WL, Wang ZY, Sun GL. Apoptotic effect of As2S2 on K562 cells and its mechanism. Acta Pharmacol Sin 2002;23:991-6.
Wang L, Zhou GB, Liu P, Song JH, Liang Y, Yan XJ, et al
. Dissection of mechanisms of Chinese medicinal formula Realgar-Indigo naturalis as an effective treatment for promyelocytic leukemia. Proc Natl Acad Sci U S A 2008;105:4826-31.
Yuan B, Iriyama N, Hu XM, Hirano T, Toyoda H, Takagi N. Perspective on Therapeutic Strategies of Leukemia Treatment — Focus on Arsenic Compounds in Book Leukemias-Updates and New Insights. 191-218. Available from https://cdn.intechopen.com/pdfs/48861.pdf
. Last retrieved on 4 May 2020 [doi.org/10.5772/60786].
Sharma M, Porte S, Charak S. In vivo
anticancer activity and toxicity of Ayurveda compound W.S.R. to leukemia. J Indian Syst Med 2019;7:20-7.
Chikitsa Sthana. Chakrapani Tika on Charak Samhita of Agnivesa by Cakrapanidatta. Vol. 3. Varanasi: Chaukhambha Subharati Prakashan; 2016. p. 400.
Nidanam J. Madhukosa on Madhavnidanam by Vijyarakshit and Srikanthadatta by Brahmananda Tripathi. Vol. 2. Varanasi: Chaukhambha Subharati Prakashan; 2016. p. 169.
Chikitsa Sthana. Chakrapani Tika on Charak Samhita of Agnivesa by Cakrapanidatta. Vol. 13. Varanasi: Chaukhambha Subharati Prakashan; 2016. p. 493.
Sthana C. Chakrapani Tika on Charak Samhita of Agnivesa by Cakrapanidatta. Vol. 3. Varanasi: Chaukhambha Subharati Prakashan; 2016. p. 409.
Surasthana. Sushrut Samhita, Shastri AmbiKadutt. Vol. 15. Varanasi: Chaukhambha Sanskrit Sansthan; 2005. 15 (4); 87
Chikitsa Sthana. Chakrapani Tika on Charak Samhita of Agnivesa by Cakrapanidatta. Vol. 4. Varanasi: Chaukhambha Subharati Prakashan; 2016. p. 428.
Surasthana. Sushrut Samhita, Shastri Ambikadutt. Vol. 18. Varanasi: Chaukhambha Sanskrit Sansthan; 2005. p. 87.
Vimana Sthana. Chakrapani Tika on Charak Samhita of Agnivesa by Cakrapanidatta. Vol. 6. Varanasi: Chaukhambha Subharati Prakashan; 2016. p. 256.
Sutrasthana. Chakrapani Tika on Charak Samhita of Agnivesa by Cakrapanidatta. Vol. 14. Varanasi: Chaukhambha Subharati Prakashan; 2016. p. 124.
Chikitsa Sthana. Chakrapani Tika on Charak Samhita of Agnivesa by Cakrapanidatta. Varanasi: Chaukhambha Subharati Prakashan; 2016. 4 (54-56);pp: 431
Poorvardha, Nidaansthana. Sushruta Samhita by KavirajDr.Ambikadutta Shastri, SushruthaSamhitha edited with Ayurveda Tatva Sandipika. Vol. 11. Varanasi: Choukambha Sanskrit Samsthan; 2015. p. 351.
Sastry JL. Introduction to oncology, Cancer in Ayurveda. Reprint edition. Varanasi: Chaukhambha Orientalia; 2016. p. 4.
Poorvardha, Chikitsa Sthana. Sushruta Samhita by Kaviraj Dr. Ambikadutta Shastri, SushruthaSamhitha edited with Ayurveda Tatva Sandipika. Vol. 18. Varanasi: Choukambha Sanskrit Samsthan; 2015. p. 904.
Poorvardha, Chikitsa Sthana. Sushruta Samhita by Kaviraj Dr.Ambikadutta Shastri, SushruthaSamhitha edited with Ayurveda Tatva Sandipika. Vol. 18. Varanasi: Choukambha Sanskrit Samsthan; 2015. p. 906.
Poorvardha, Chikitsa Sthana. Sushruta Samhita by Kaviraj Dr.Ambikadutta Shastri, SushruthaSamhitha edited with Ayurveda Tatva Sandipika. Vol. 18. Varanasi: Choukambha Sanskrit Samsthan; 2015. p. 905.
Samhitha S, editor. Sushruta Samhita by Kaviraj Dr. Ambikadutta Shastri. Poorvardha, Sutra Sthana. Ayurveda Tatva Sandipika. Vol. 15. Varanasi: Choukambha Sanskrit Samsthan; 2015. p. 74.
Sharma RK, Das B, editors. Athatatrishothiyaadhyaya. Charaka Samhita of Agnivesha, Sutrasthana. Ch. 18. Verse 51. Varanasi: Choukhmbha Sanskrit Series Office; 2014. p. 346.
Pal D, Sahu CK, Haldar A. Bhasma: The ancient Indian nanomedicine. J Adv Pharm Technol Res 2014;5:4-12.
] [Full text]
Jain R, Kosta S, Tiwari A. Ayurveda and cancer. Pharmacognosy Res 2010;2:393-4.
Prakash VB, Pal SK. A review on an Ayurvedic approach for cancer treatment. Int J Interdiscipl Multidiscipl Stud 2014;1:1-11.
Pal SK. A review on an Ayurvedic approach for cancer treatment developed by Vaidya Balendu Prakash. Int J Interdiscipl Multidiscipl Stud 2014;1:1-11.
Acharya Priyavrat Sharma, Dravyaguna Vigyan. Vol. 11. Varanasi: Chaukhamba Bharati Academy; 2011. p. 763-5.
Acharya Priyavrat Sharma, Dravyaguna Vigyan. Vol. 11. Varanasi: Chaukhamba Bharati Academy; 2011. p. 164-5.
Acharya Priyavrat Sharma, Dravyaguna Vigyan. Vol. 11. Varanasi: Chaukhamba Bharati Academy; 2011. p. 544-5.
Acharya Priyavrat Sharma, Dravyaguna Vigyan. Vol. 11. Varanasi: Chaukhamba Bharati Academy; 2011. p. 333-5.
Acharya Priyavrat Sharma, Dravyaguna Vigyan. Vol. 11. Varanasi: Chaukhamba Bharati Academy; 2011. p. 437-9.
Acharya Priyavrat Sharma, Dravyaguna Vigyan. Vol. 11. Varanasi: Chaukhamba Bharati Academy; 2011. p. 168-70.
Acharya Priyavrat Sharma, Dravyaguna Vigyan. Vol. 11. Varanasi: Chaukhamba Bharati Academy; 2011. p. 761-3.
Acharya Priyavrat Sharma, Dravyaguna Vigyan. Vol. 11. Varanasi: Chaukhamba Bharati Academy; 2011. p. 111-4.
Acharya Priyavrat Sharma, Dravyaguna Vigyan. Vol. 11. Varanasi: Chaukhamba Bharati Academy; 2011. p. 133-5.
Acharya Priyavrat Sharma, Dravyaguna Vigyan. Vol. 11. Varanasi: Chaukhamba Bharati Academy; 2011. p. 9-10.
Acharya Priyavrat Sharma, Dravyaguna Vigyan. Vol. 11. Varanasi: Chaukhamba Bharati Academy; 2011. p. 560-2.
Acharya Priyavrat Sharma, Dravyaguna Vigyan. Vol. 11. Varanasi: Chaukhamba Bharati Academy; 2011. p. 340-3.
Acharya Priyavrat Sharma, Dravyaguna Vigyana. Vol. 11. Varanasi: Chaukhamba Bharati Academy; 2011. p. 28-9.
Acharya Priyavrat Sharma, Dravyaguna Vigyana. Vol. 11. Varanasi: Chaukhamba Bharati Academy; 2011. p. 446-7.
Acharya Priyavrat Sharma, Dravyaguna Vigyana. Vol. 11. Varanasi: Chaukhamba Bharati Academy; 2011. p. 562-3.
Acharya Priyavrat Sharma, Dravyaguna Vigyana. Vol. 11. Varanasi: Chaukhamba Bharati Academy; 2011. p. 129-30.
Acharya Priyavrat Sharma, Dravyaguna Vigyana. Vol. 11. Varanasi: Chaukhamba Bharati Academy; 2011. p. 858-9.
Acharya Priyavrat Sharma, Dravyaguna Vigyana. Vol. 11. Varanasi: Chaukhamba Bharati Academy; 2011. p. 549-50.
Acharya Priyavrat Sharma, Dravyaguna Vigyana.Vol. 11. Varanasi: Chaukhamba Bharati Academy; 2011. p. 684-5.
Acharya Priyavrat Sharma, Dravyaguna Vigyana. Vol. 11. Varanasi: Chaukhamba Bharati Academy; 2011. p. 552-4.
Acharya Priyavrat Sharma, Dravyaguna Vigyana. Vol. 11. Varanasi: Chaukhamba Bharati Academy; 2011. p. 661-3.
Acharya Priyavrat Sharma, Dravyaguna Vigyana. Vol. 11. Varanasi: Chaukhamba Bharati Academy; 2011. p. 150-1.
Acharya Priyavrat Sharma, Dravyaguna Vigyana. Vol. 11. Varanasi: Chaukhamba Bharati Academy; 2011. p. 596-7.
Acharya Priyavrat Sharma, Dravyaguna Vigyana. Vol. 11. Varanasi: Chaukhamba Bharati Academy; 2011. p. 513-4.
Acharya Priyavrat Sharma, Dravyaguna Vigyana. Vol. 11. Varanasi: Chaukhamba Bharati Academy; 2011. p. 783-5.
Acharya Priyavrat Sharma, Dravyaguna Vigyana, Vol. 11. Varanasi: Chaukhamba Bharati Academy; 2011. p. 491-4.
Acharya Priyavrat Sharma, Dravyaguna Vigyana. Vol. 11. Varanasi: Chaukhamba Bharati Academy; 2011. p. 501-3.
Acharya Priyavrat Sharma, Dravyaguna Vigyana. Vol. 11. Varanasi: Chaukhamba Bharati Academy; 2011. p. 801-2.
Acharya Priyavrat Sharma, Dravyaguna Vigyana. Vol. 11. Varanasi: Chaukhamba Bharati Academy; 2011. p. 829-31.
Goel S, Arya D, Sharma OR, Sharma SK. Review on Rudanti: An imperative drug mentioned in Ayurveda as Rasayana for chronic ailments. Int Ayurved Med J 2017;5(8): 2920-26.
Acharya Priyavrat Sharma, Dravyaguna Vigyana. Vol. 11. Varanasi: Chaukhamba Bharati Academy; 2011. p. 345-7.
Acharya Priyavrat Sharma, Dravyaguna Vigyana. Vol. 11. Varanasi: Chaukhamba Bharati Academy; 2011. p. 54-8.
Kaviraja Ambikadutta Shastri, Sushrut Samhita of Sushrut, Chikitsa Sthana. Ch. 18. Verse 34. Varanasi: Chaukhambha Sanskrit Sansthan; 2012. p. 107-8.
Kaviraja Ambikadutta Shastri, Sushrut Samhita of Sushrut. Reprint 2012, Chikitsa Sthana, Ch. 19. Verse 41. Varanasi: Chaukhambha Sanskrit Sansthan; 2012. p. 108-9.
Chatergi P, Rasa Chikitsa. 2nd
ed.. Varanasi: Chaukhambha Bharati Academy;2014. p. 23-5.
Kulkarni SB. editor, Hindi Commentary. In: Rasa Ratna Samucchaya, Reprint. 1st
ed.., Ch. 8. Verse 5. Kolhapur, India: Shivaji University Publications; 1970. p. 154.
Sharma SS, Tarangini R, Edited by Kashinath Shastri, 11th
edition, New Delhi, Motilal Banarasidas Publication; 2004 (15). p -267.
Pandey BN. Ayurvediya Rasashastra. Rasadi Varnana Khand, Malla Vigyan. 2nd
ed.. Varanasi: Chaukhambha Surbharti Prakashana; 2017. p. 111.
Madhava A, Prakash A. Shri Guljar Sharma and Mishra, Reprint, Ch. 2, Verse- 218. Varanasi: Chowkhamba Bharati Acadamy; 2016. p. 313.
Pandey BN. Ayurvediya Rasashastra. Rasadi Varnana Khand, Malla Vigyan. 2nd
ed.. Varanasi: Chaukhambha Surbharti Prakashana; 2017. p. 115.
Yang MH, Wan WQ, Luo JS, Zheng MC, Huang K, Yang LH, et al
. Multicenter randomized trial of arsenic trioxide and Realgar-Indigo naturalis formula in pediatric patients with acute promyelocytic leukemia: Interim results of the SCCLG-APL clinical study. Am J Hematol 2018;93:1467-73.
Sharma M, Porte SM. Role of Ayurveda in management of leukemia (Raktarbuda)
. IJPSR. 2016;7:520-30.
Xiao Q, Zhu W, Feng W, Lee SS, Leung AW, Shen J, et al
. A review of resveratrol as a potent chemoprotective and synergistic agent in cancer chemotherapy. Front Pharmacol 2018;9:1534.
Baliga MS, Rao S, Rai MP, D'souza P. Radioprotective effects of the Ayurvedic medicinal plant Ocimum sanctum
Linn. (Holy Basil): A memoir. J Cancer Res Ther 2016;12:20-7.
Baliga MS. Triphala
, Ayurvedic formulation for treating and preventing cancer: A review. J Altern Complement Med 2010;16:1301-8.
Sharma P, Parmar J, Sharma P, Verma P, Goyal PK. Radiation-induced testicular injury and its amelioration by Tinospora cordifolia
(An Indian Medicinal Plant) extract. Evid Based Complement Alternat Med 2011;2011:643847.
Goel HC, Prem Kumar I, Rana SV. Free radical scavenging and metal chelation by Tinospora cordifolia
, a possible role in radioprotection. Indian J Exp Biol 2002;40:727-34.
[Table 1], [Table 2], [Table 3], [Table 4]